Summary

Japan has a significant and growing population of individuals with diabetes. The increasing prevalence of diabetes, particularly type 2 diabetes, creates a higher demand for insulin and insulin delivery devices for effective disease management. Japan has one of the world's most rapidly aging populations. Older individuals are more prone to diabetes, leading to an increased need for insulin therapy. This demographic shift contributes to the growth of the insulin delivery devices market. Japan boasts a highly advanced healthcare infrastructure with a strong emphasis on technological innovation. This environment supports the development, adoption, and integration of advanced insulin delivery devices into the healthcare system. Continuous innovations in insulin delivery devices, such as smart insulin pens, pumps, and continuous glucose monitoring (CGM) systems, contribute to market growth. Japanese manufacturers and international companies operating in Japan often introduce cutting-edge technologies to meet the evolving needs of patients. Japanese patients, particularly in urban areas, often have a high level of acceptance for technological solutions. The preference for convenient and user-friendly insulin delivery devices aligns with the country's tech-savvy population. Precision medicine, tailoring healthcare interventions to individual characteristics, is gaining prominence in Japan. This approach may lead to the development and adoption of personalized insulin delivery solutions based on patients' specific needs and responses. Japan has a cultural emphasis on health and wellbeing, reflected in dietary habits, lifestyle choices, and healthcare practices. This awareness and focus on preventive healthcare contribute to a positive environment for the growth of the insulin delivery devices market. Efforts to educate healthcare professionals and the public about diabetes management and the importance of timely insulin delivery have likely contributed to increased awareness and adoption of insulin delivery devices.

According to the research report "Japan Insulin Delivery Devices Market Overview, 2028," published by Bonafide Research, the Japan Insulin Delivery Devices market is expected to reach market size of more than USD 850 Million by 2028. Japan has shown cultural acceptance and a strong market for wearable technology. Insulin delivery devices integrated with wearable solutions, such as smartwatches or health monitoring devices, may find a favorable reception in the Japanese market. The integration of smart technology into insulin delivery devices, such as smart insulin pens and pumps, continues to be a trend. These devices may offer features like connectivity to mobile apps for real-time monitoring, dosage tracking, and data sharing with healthcare providers. The integration of continuous glucose monitoring systems with insulin delivery devices is becoming more common. This trend enables individuals with diabetes to have a more comprehensive view of their glucose levels, allowing for more precise insulin administration. Manufacturers are focusing on designing insulin delivery devices that are user-friendly, with intuitive interfaces and ergonomic designs. This trend aims to enhance the overall patient experience and improve adherence to insulin therapy. There is a growing demand for compact and portable insulin delivery devices that are convenient for daily use, particularly for individuals with active lifestyles. Compact devices enhance ease of carrying and discreet usage. The shift towards value-based healthcare models, where the emphasis is on improving patient outcomes and reducing overall healthcare costs, is influencing the development and adoption of insulin delivery devices that contribute to better health outcomes. As awareness of diabetes in children increases, there may be a growing focus on developing insulin delivery devices specifically designed for pediatric use. Child-friendly designs and features may become more prevalent in the market. Innovations in needle technologies, such as shorter and thinner needles, aim to enhance the comfort of insulin administration. Needle-free or painless delivery methods are also areas of exploration in the development of insulin delivery devices.

Based on product market is majorly segmented into insulin pens, insulin pumps, insulin pen needles, insulin syringes and others insulin delivery devices(insulin transdermal patches, insulin inhalers, insulin jet injection). Insulin pumps are gaining significant traction in Japan insulin delivery devices market. One of the key reasons for the increasing popularity of insulin pumps in the Japan is their capacity to administer accurate and personalised insulin. These devices provide continuous subcutaneous insulin infusion, simulating the actions of a healthy pancreas by continually administering basal insulin throughout the day. This feature enables a more tightly regulated insulin profile, giving patients greater flexibility in modifying basal rates to match their particular metabolic needs, resulting in better glycemic management. Furthermore, insulin pumps provide more precise bolus dosing, which is especially useful for mealtime insulin delivery. The ability to provide exact boluses based on meal size and carbohydrate intake contributes to better overall glucose management by optimising postprandial glucose levels. This level of precision is challenging to achieve consistently with traditional insulin injection methods, making pumps an appealing option for patients aiming for tighter glucose control.

Based on end user segment market is bifurcated into home care, hospitals and clinics and others. Hospitals and clinics are playing pivotal role in development of Japan insulin delivery devices market. These healthcare facilities are used to test novel insulin delivery technologies. Clinical trials, research studies, and pilot programmes are frequently carried out in hospital settings to assess the safety, efficacy, and usability of new insulin delivery methods. This environment enables real-world testing and validation of devices before they are released to the market, ensuring that they meet high quality and regulatory criteria. Hospitals and clinics help to obtain real-world data on insulin delivery devices. In these contexts, patient outcomes, usage patterns, and device performance data give valuable insights for evidence-based practice. This data analysis helps healthcare practitioners and device makers improve device features and treatment processes, ultimately improving patient care. In terms of indication market includes diabetes, pregnancy, cardiovascular disorders & hypertension, respiratory diseases, hearing disorders, cancer, movement disorders, wound care and other indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV). Among them insulin delivery devices are gaining significant demand among the cardiovascular disorders & hypertension patients in Japan. Diabetes is inextricably connected to cardiovascular disease and high blood pressure. Diabetes patients are more likely to have cardiovascular issues such as heart disease, stroke, and hypertension. Diabetes with poorly regulated blood sugar levels increases the risk of cardiovascular events and hypertension. The healthcare system in the Japan prioritises patient-centred treatment and comprehensive illness management. Insulin delivery devices enable a more patient-centred approach to diabetes care, allowing individuals to better manage their illness and reduce the risk of cardiovascular problems.

Considered in this report:
• Geography: Japan
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• Japan Insulin Delivery Devices market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product
• Insulin Pens
• Insulin Pumps
• Insulin Pen Needles
• Insulin Syringes
• Others Insulin Delivery Devices (Insulin transdermal patches, insulin inhalers, insulin jet injection)

By Indication
• Diabetes
• Pregnancy
• Cardiovascular Disorders & Hypertension
• Respiratory Diseases
• Hearing Disorders
• Cancer
• Movement Disorders
• Wound Care

By End User
• Home Care
• Hospitals & Clinics
• Others

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Insulin Delivery Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents